Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Marburg virus genomic RNA is a single-stranded, negative-sense RNA molecule of approximately 19 kilobases that serves as the genetic blueprint for the Marburg virus (MARV), a highly pathogenic member of the Filoviridae family (NCBI Genome, 2024). The genome encodes seven structural proteins, including the nucleoprotein (NP), VP35, VP40, glycoprotein (GP), VP30, VP24, and the RNA-dependent RNA polymerase (L), which are essential for viral entry, replication, and assembly (Kuhlmann et al., 2018). During the viral life cycle, the genomic RNA acts as a template for the synthesis of viral messenger RNAs and a positive-sense antigenome intermediate (WHO, 2023). As the central component of viral persistence and pathogenesis, MARV RNA is a critical target for therapeutic strategies, including antisense oligonucleotides (e.g., AVI-7288) and small interfering RNAs (e.g., TKM-Marburg) that bind directly to the RNA to prevent translation or induce degradation (Warren et al., 2014; Thi et al., 2015). Additionally, the replication process of this RNA is targeted by nucleoside analogs such as Remdesivir and Galidesivir, which act as alternative substrates for the viral polymerase, leading to premature termination of the nascent RNA strand (Warren et al., 2016; Taylor et al., 2016).
Sequence-specific binding by antisense or siRNA to block translation/degradation, or inhibition of RNA synthesis via nucleoside analog chain termination.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Marburg virus genomic RNA (MARV RNA).